Encompass Health Corporation
US ˙ NYSE ˙ US29261A1007

Introduction

This page provides a comprehensive analysis of the known insider trading history of Edward A Blechschmidt. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Edward A Blechschmidt has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:VWR / VWR Corporation Director 0
US:LIOX / Lionbridge Technologies, Inc. Director 0
US:DMND / Diamond Foods, Inc. Director 0
US:CBRX / Director 18,201
US:HLS / HEALTHSOUTH Corp. Director 52,844
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Edward A Blechschmidt. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EHC / Encompass Health Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EHC / Encompass Health Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2012-03-06 HLS BLECHSCHMIDT EDWARD A 2,000 20.0100 2,000 20.0100 40,020 730
2012-03-02 HLS BLECHSCHMIDT EDWARD A 200 20.0100 200 20.0100 4,002
2012-03-01 HLS BLECHSCHMIDT EDWARD A 1,000 20.4500 1,000 20.4500 20,450

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EHC / Encompass Health Corporation Insider Trades
Insider Sales EHC / Encompass Health Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EHC / Encompass Health Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EHC / Encompass Health Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Edward A Blechschmidt as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2017-11-22 2017-11-21 4 VWR VWR Corp
Director stock option (right to buy)
D - Sale to Issuer -17,617 0 -100.00 12.25 -215,808
2017-11-22 2017-11-21 4 VWR VWR Corp
Common stock
D - Sale to Issuer -12,617 0 -100.00 33.25 -419,515
2017-03-02 2017-02-28 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted stock units
D - Sale to Issuer -7,099 0 -100.00 5.75 -40,819
2017-03-02 2017-02-28 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted stock units
D - Sale to Issuer -78,483 0 -100.00 5.75 -451,277
2017-03-02 2017-02-28 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
stock option (right to buy)
D - Sale to Issuer -8,197 0 -100.00 0.82 -6,722
2017-03-02 2017-02-28 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
stock option (right to buy)
D - Sale to Issuer -6,024 0 -100.00 0.19 -1,145
2017-03-02 2017-02-28 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
D - Sale to Issuer -82,500 0 -100.00 5.75 -474,375
2017-03-02 2017-02-28 4 VWR VWR Corp
Common stock
A - Award 3,539 12,617 38.98
2016-05-05 2016-05-03 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted share units
A - Award 7,099 7,099
2016-05-05 2016-05-03 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option with right to purchase
A - Award 8,197 8,197 4.93 40,411 40,411
2016-03-03 2016-03-02 4 VWR VWR Corp
Common stock
A - Award 4,078 9,078 81.56
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00
2016-03-02 2016-02-29 4 DMND Diamond Foods Inc
Common Stock
D - Sale to Issuer -7,943 0 -100.00
2016-01-29 2011-03-25 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
A - Award 10,000 10,000
2016-01-29 2010-03-25 4 DMND Diamond Foods Inc
Common Stock
F - Taxes -1,189 7,943 -13.02
2015-11-18 2015-11-17 4 VWR VWR Corp
Director stock option (right to buy)
M - Exercise -5,000 17,617 -22.11
2015-11-18 2015-11-17 4 VWR VWR Corp
Common stock
M - Exercise 5,000 5,000 21.00 105,000 105,000
2015-05-08 2015-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
M - Exercise -10,000 0 -100.00 3.36 -33,600
2015-05-08 2015-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
M - Exercise -10,000 0 -100.00 2.67 -26,700
2015-05-08 2015-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 82,500 13.79 3.36 33,600 277,200
2015-05-08 2015-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 72,500 16.00 2.67 26,700 193,575
2015-05-05 2015-05-04 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted share units
A - Award 6,295 6,295
2015-05-05 2015-05-04 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
A - Award 6,024 6,024 5.56 33,493 33,493
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
M - Exercise -10,000 0 -100.00 5.75 -57,500
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
M - Exercise -10,000 0 -100.00 4.27 -42,700
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to purchase
M - Exercise -5,000 0 -100.00 3.21 -16,050
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 62,500 19.05 5.75 57,500 359,375
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 52,500 23.53 4.27 42,700 224,175
2015-05-01 2015-04-30 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 5,000 42,500 13.33 3.21 16,050 136,425
2015-01-16 2015-01-14 4 DMND Diamond Foods Inc
Common Stock
A - Award 2,891 9,132 46.32
2014-10-07 2014-10-07 4 VWR VWR Corp
Director Stock Option (right to buy)
A - Award 22,617 22,617
2014-05-13 2014-05-08 4 CBRX COLUMBIA LABORATORIES INC
$.01 Par Value Common Stock
F - Taxes -3,024 18,201 -14.25 6.57 -19,868 119,581
2014-05-08 2014-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted stock unit
A - Award 5,932 5,932
2014-05-08 2014-05-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option (right to buy)
A - Award 5,885 5,885 5.90 34,722 34,722
2014-03-26 2014-03-25 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
A - Award 10,000 10,000
2014-03-10 2014-03-06 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
S - Sale -35,000 37,500 -48.28 7.23 -253,050 271,125
2013-07-01 2013-05-01 4 CBRX COLUMBIA LABORATORIES INC
$.01 Par Value Common Stock
F - Taxes -15,441 169,803 -8.34 0.62 -9,573 105,278
2013-05-17 2013-05-16 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
P - Purchase 10,000 72,500 16.00 2.63 26,280 190,530
2013-05-07 2013-05-03 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted stock unit
A - Award 8,928 8,928
2013-05-07 2013-05-03 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option (right to buy)
A - Award 10,000 10,000 3.36 33,600 33,600
2013-05-03 2013-05-01 4 CBRX COLUMBIA LABORATORIES INC
$.01 Par Value Common Stock
A - Award 48,387 169,803 39.85 0.01 484 1,698
2013-03-25 2013-03-25 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
A - Award 10,000 10,000
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to buy
M - Exercise -5,000 0 -100.00 3.21 -16,050
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option right to buy
M - Exercise -10,000 0 -100.00 1.39 -13,900
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option (right to buy)
M - Exercise -10,000 0 -100.00 2.43 -24,300
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 5,000 62,500 8.70 3.21 16,050 200,625
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 57,500 21.05 1.39 13,900 79,925
2013-01-16 2013-01-14 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 10,000 47,500 26.67 2.43 24,300 115,425
2012-08-01 2012-07-31 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
common stock
M - Exercise 27,500 37,500 275.00 1.85 50,875 69,375
2012-08-01 2003-02-04 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option (right to buy)
M - Exercise -27,500 0 -100.00 1.85 -50,875
2012-06-11 2012-06-07 4 cbrx COLUMBIA LABORATORIES INC
$.01 Par Value Common Stock
A - Award 44,117 136,587 47.71 0.01 441 1,366
2012-05-03 2012-05-01 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
restricted stock unit
A - Award 11,236 11,236
2012-05-03 2012-05-01 4 LIOX LIONBRIDGE TECHNOLOGIES INC /DE/
option (right to buy)
A - Award 10,000 10,000 2.67 26,700 26,700
2012-04-12 2012-04-11 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
J - Other 5 52,844 0.01 20.29 101 1,072,205
2012-04-12 2012-04-10 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
J - Other 90 52,839 0.17 20.00 1,800 1,056,780
2012-03-27 2012-03-26 4 DMND Diamond Foods Inc
Director Stock Option (right to buy)
A - Award 10,000 10,000
2012-03-06 2012-03-06 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
P - Purchase 2,000 52,749 3.94 20.01 40,020 1,055,507
2012-03-05 2012-03-02 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
P - Purchase 200 50,749 0.40 20.01 4,002 1,015,487
2012-03-01 2012-03-01 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
P - Purchase 1,000 50,549 2.02 20.45 20,450 1,033,727
2012-02-27 2012-02-24 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
A - Award 4,767 49,549 10.64
2012-01-09 2012-01-09 4 HLS HEALTHSOUTH CORP
Healthsouth Common Stock
J - Other 325 44,782 0.73 17.54 5,700 785,476
2008-01-03 2008-01-01 4 HLS HEALTHSOUTH CORP
HEALTHSOUTH Common Stock
D - Sale to Issuer -265 9,655 -2.67 21.00 -5,565 202,755
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)